Article Topic
The End of GLP-1 Compounding
Federally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.
[...]May 27, 2025: Global effort to disrupt darknet marketplaces yields 4,400 pounds of illicit drugs
Operation RapTor led to 270 arrests and the seizure of more than $200 million in currency and digital assets.
[...]May 19, 2025: Investigations raise questions about product safety at a Texas compounding company
Exposes in the Houston Chronicle and Endpoints News examined Empower Pharmacy’s safety record. A grand jury indicted a Chinese company and three of its employees for pill press and counterfeit die mold sales.
[...]Case overview, USA v Capsulcn International Co Ltd et al (2025 — ) – ongoing
In May 2025, the U.S. District Court in the Western District of Texas unsealed an indictment against a CapsulCN International and three Chinese nationals for their alleged role in the illegal importation of pill-making equipment.
[...]Indictment, USA v CapsulCN International Co Ltd et al
April 23, 2025
[...]May 12, 2025: FDA will expand unannounced foreign facility inspections, it says
The FDA wants to ensure that domestic and foreign companies receive the same level of regulatory oversight.
Catch up on research PSM released about medicines imported from unregistered sources.
[...]Prescription Drug Freight Fraud Report, May 2025
What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.
[...]Pharmaceutical Border Security
Pharmaceutical border security Every day, inspectors from Customs and Border Protection, the Food and Drug Administration, and the Drug Enforcement Administration intercept scary medical products entering the U.S. This work is incredibly important to protect the safety of American patients and it’s difficult because criminals never stop innovating. PSM supports the work of border inspectors…
[...]Case overview, Gilead Sciences v Heal the World et al (2025 — ) – ongoing
Gilead Sciences has filed a civil complaint against a Queens, New York-based pharmacy that allegedly sold counterfeit HIV medicine.
[...]Oregon State Pharmacy Association submits testimony to Oregon’s PDAB
Oregon State Pharmacy Association submits testimony to Oregon’s PDAB On May 6, the Oregon State Pharmacy Association (OSPA) submitted testimony for the Oregon Prescription Drug Affordability Board’s May 2025 meeting, suggesting that the board eliminate PBM spread pricing to improve prescription drug affordability. Read it here. Read the PDF. Learn more about: Upper payment limits…
[...]